PDT Partners’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-90,298
| Closed | -$1.53M | – | 740 |
|
|
2024
Q4 | $1.53M | Buy |
90,298
+15,154
| +20% | +$257K | 0.14% | 256 |
|
|
2024
Q3 | $1.74M | Buy |
+75,144
| New | +$1.74M | 0.15% | 243 |
|
|
2022
Q3 | – | Sell |
-74,636
| Closed | -$1.18M | – | 836 |
|
|
2022
Q2 | $1.18M | Buy |
74,636
+25,136
| +51% | +$396K | 0.1% | 342 |
|
|
2022
Q1 | $1.34M | Sell |
49,500
-3,523
| -7% | -$95K | 0.11% | 283 |
|
|
2021
Q4 | $1.96M | Buy |
53,023
+3,523
| +7% | +$130K | 0.15% | 240 |
|
|
2021
Q3 | $2.37M | Buy |
+49,500
| New | +$2.37M | 0.17% | 228 |
|
|
2016
Q2 | – | Sell |
-2,200
| Closed | -$58K | – | 445 |
|
|
2016
Q1 | $58K | Hold |
2,200
| – | – | ﹤0.01% | 555 |
|
|
2015
Q4 | $97K | Buy |
+2,200
| New | +$97K | 0.01% | 378 |
|